|
1
|
Buoli M, Grassi S, Serati M, Altamura AC. Agomelatine for the treatment of generalized anxiety disorder. Expert Opin Pharmacother 2017; 18:1373-1379. [DOI: 10.1080/14656566.2017.1359257] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- Massimiliano Buoli
- Department of Psychiatry, University of Milan, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico , Milan, Italy
| | - Silvia Grassi
- Department of Psychiatry, University of Milan, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico , Milan, Italy
| | - Marta Serati
- Department of Psychiatry, University of Milan, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico , Milan, Italy
| | - A. Carlo Altamura
- Department of Psychiatry, University of Milan, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico , Milan, Italy
| |
Collapse
|
|
2
|
Canpolat S, Ulker N, Yardimci A, Bulmus O, Ozdemir G, Sahin Z, Ercan Z, Serhatlioglu I, Kacar E, Ozcan M, Turk G, Ozkan Y, Atmaca M, Yilmaz B, Kelestimur H. Studies on the reproductive effects of chronic treatment with agomelatine in the rat. Eur J Pharmacol 2015; 770:33-9. [PMID: 26643170 DOI: 10.1016/j.ejphar.2015.11.054] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2015] [Revised: 11/25/2015] [Accepted: 11/27/2015] [Indexed: 11/15/2022]
Abstract
Agomelatine is an antidepressant with a novel mechanism of action. It is a melatonergic agonist for MT1 and MT2 receptors and a serotonin (5-HT2C) receptor antagonist. Agomelatine has been suggested not to have adverse effects on sexual functions. However, the effects of chronic agomelatine administration on reproductive functions have not been sufficiently studied in animal models. We mainly aimed to explore the effects of agomelatine on reproductive functions in the male and female rats. For the experimental studies, Sprague Dawley rats were used. The animals started to receive daily oral agomelatine (10mg/kg) on post-natal day 21. Agomelatine advanced vaginal opening in the female rats whereas it delayed puberty onset in the male rats. Agomelatine treatment significantly decreased intromission frequencies, which indicates a facilitator role of this antidepressant on male sexual behavior. In the forced swimming test (FST) used for assessing antidepressant efficacy, agomelatine induced a significant decrease in duration of immobility, and an increase in the swimming time, respectively, which confirms the antidepressant-like activity of agomelatine. The present findings suggest that agomelatine shows a strong antidepressant effect in the male rats without any adverse influences on sexual behavior, and its effects on pubertal maturation seem to show sex-dependent differences.
Collapse
Affiliation(s)
- Sinan Canpolat
- Firat University, Medical School, Department of Physiology, Elazig, Turkey
| | - Nazife Ulker
- Firat University, Medical School, Department of Physiology, Elazig, Turkey
| | - Ahmet Yardimci
- Firat University, Medical School, Department of Physiology, Elazig, Turkey
| | - Ozgur Bulmus
- Firat University, Medical School, Department of Physiology, Elazig, Turkey
| | - Gokcen Ozdemir
- Firat University, Medical School, Department of Physiology, Elazig, Turkey
| | - Zafer Sahin
- Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Necmettin Erbakan University, Konya, Turkey
| | - Zubeyde Ercan
- Firat University, Medical School, Department of Physiology, Elazig, Turkey
| | - Ihsan Serhatlioglu
- Firat University, Medical School, Department of Biophysics, Elazig, Turkey
| | - Emine Kacar
- Firat University, Medical School, Department of Physiology, Elazig, Turkey
| | - Mete Ozcan
- Firat University, Medical School, Department of Biophysics, Elazig, Turkey
| | - Gaffari Turk
- Faculty of Veterinary Medicine, Department of Reproduction and Artificial Insemination, Firat University, Elazig, Turkey
| | - Yusuf Ozkan
- Firat University, Medical School, Department of Endocrinology and Metabolism, Elazig, Turkey
| | - Murad Atmaca
- Firat University, Medical School, Department of Psychiatry, Elazig, Turkey
| | - Bayram Yilmaz
- Yeditepe University, Medical School, Department of Physiology, Istanbul, Turkey
| | - Haluk Kelestimur
- Firat University, Medical School, Department of Physiology, Elazig, Turkey.
| |
Collapse
|